Call our support: +31 20 8084 414
Google Reviews
4.8
Toggle Nav
Search
Advanced Search
You are reading an automatically translated version of our website that may contain translation errors.
Change to English
Menu
Account

TOMORROW'S MEDICINES TODAY

Compare Breast Cancer medicines

Compare Breast Cancer medicines

Afinitor (everolimus) vs Kadcyla (trastuzumab emtansine)
Afinitor (everolimus) vs Margenza (margetuximab-cmkb)
Afinitor (everolimus) vs Nerlynx (neratinib)
Afinitor (everolimus) vs Orserdu (elacestrant)
Afinitor (everolimus) vs Phesgo (pertuzumab, trastuzumab, and hyaluronidase)
Afinitor (everolimus) vs Piqray (alpelisib)
Afinitor (everolimus) vs Talzenna (talazoparib)
Afinitor (everolimus) vs Trodelvy (sacituzumab govitecan-hziy)
Afinitor (everolimus) vs Truqap (capivasertib)
Afinitor (everolimus) vs Tukysa (tucatinib)
Afinitor (everolimus) vs Xeloda ()
Enhertu (fam-trastuzumab deruxtecan-nxki) vs Margenza (margetuximab-cmkb)
Enhertu (fam-trastuzumab deruxtecan-nxki) vs Orserdu (elacestrant)
Enhertu (fam-trastuzumab deruxtecan-nxki) vs Phesgo (pertuzumab, trastuzumab, and hyaluronidase)
Enhertu (fam-trastuzumab deruxtecan-nxki) vs Trodelvy (sacituzumab govitecan-hziy)
Enhertu (fam-trastuzumab deruxtecan-nxki) vs Truqap (capivasertib)
Enhertu (fam-trastuzumab deruxtecan-nxki) vs Tukysa (tucatinib)
Ibrance (palbociclib) vs Afinitor (everolimus)
Ibrance (palbociclib) vs Enhertu (fam-trastuzumab deruxtecan-nxki)
Ibrance (palbociclib) vs Kadcyla (trastuzumab emtansine)
Ibrance (palbociclib) vs Margenza (margetuximab-cmkb)
Ibrance (palbociclib) vs Nerlynx (neratinib)
Ibrance (palbociclib) vs Orserdu (elacestrant)
Ibrance (palbociclib) vs Phesgo (pertuzumab, trastuzumab, and hyaluronidase)
Ibrance (palbociclib) vs Piqray (alpelisib)
Ibrance (palbociclib) vs Talzenna (talazoparib)
Ibrance (palbociclib) vs Trodelvy (sacituzumab govitecan-hziy)
Ibrance (palbociclib) vs Truqap (capivasertib)
Ibrance (palbociclib) vs Tukysa (tucatinib)
Ibrance (palbociclib) vs Verzenio/Verzenios (abemaciclib)
Ibrance (palbociclib) vs Xeloda ()
Kadcyla (trastuzumab emtansine) vs Enhertu (fam-trastuzumab deruxtecan-nxki)
Kadcyla (trastuzumab emtansine) vs Margenza (margetuximab-cmkb)
Kadcyla (trastuzumab emtansine) vs Orserdu (elacestrant)
Kadcyla (trastuzumab emtansine) vs Phesgo (pertuzumab, trastuzumab, and hyaluronidase)
Kadcyla (trastuzumab emtansine) vs Trodelvy (sacituzumab govitecan-hziy)
Kadcyla (trastuzumab emtansine) vs Truqap (capivasertib)
Kadcyla (trastuzumab emtansine) vs Tukysa (tucatinib)
Keytruda (pembrolizumab) vs Ibrance (palbociclib)
Keytruda (pembrolizumab) vs Kadcyla (trastuzumab emtansine)
Keytruda (pembrolizumab) vs Margenza (margetuximab-cmkb)
Keytruda (pembrolizumab) vs Nerlynx (neratinib)
Keytruda (pembrolizumab) vs Orserdu (elacestrant)
Keytruda (pembrolizumab) vs Phesgo (pertuzumab, trastuzumab, and hyaluronidase)
Keytruda (pembrolizumab) vs Piqray (alpelisib)
Keytruda (pembrolizumab) vs Talzenna (talazoparib)
Keytruda (pembrolizumab) vs Trodelvy (sacituzumab govitecan-hziy)
Keytruda (pembrolizumab) vs Truqap (capivasertib)
Keytruda (pembrolizumab) vs Tukysa (tucatinib)
Keytruda (pembrolizumab) vs Verzenio/Verzenios (abemaciclib)
Keytruda (pembrolizumab) vs Xeloda ()
Kisqali (ribociclib) vs Afinitor (everolimus)
Kisqali (ribociclib) vs Enhertu (fam-trastuzumab deruxtecan-nxki)
Kisqali (ribociclib) vs Ibrance (palbociclib)
Kisqali (ribociclib) vs Kadcyla (trastuzumab emtansine)
Kisqali (ribociclib) vs Keytruda (pembrolizumab)
Kisqali (ribociclib) vs Margenza (margetuximab-cmkb)
Kisqali (ribociclib) vs Nerlynx (neratinib)
Kisqali (ribociclib) vs Orserdu (elacestrant)
Kisqali (ribociclib) vs Phesgo (pertuzumab, trastuzumab, and hyaluronidase)
Kisqali (ribociclib) vs Piqray (alpelisib)
Kisqali (ribociclib) vs Talzenna (talazoparib)
Kisqali (ribociclib) vs Trodelvy (sacituzumab govitecan-hziy)
Kisqali (ribociclib) vs Truqap (capivasertib)
Kisqali (ribociclib) vs Tukysa (tucatinib)
Kisqali (ribociclib) vs Verzenio/Verzenios (abemaciclib)
Kisqali (ribociclib) vs Xeloda ()
Lynparza (olaparib) vs Afinitor (everolimus)
Lynparza (olaparib) vs Enhertu (fam-trastuzumab deruxtecan-nxki)
Lynparza (olaparib) vs Ibrance (palbociclib)
Lynparza (olaparib) vs Kadcyla (trastuzumab emtansine)
Lynparza (olaparib) vs Keytruda (pembrolizumab)
Lynparza (olaparib) vs Kisqali (ribociclib)
Lynparza (olaparib) vs Margenza (margetuximab-cmkb)
Lynparza (olaparib) vs Nerlynx (neratinib)
Lynparza (olaparib) vs Orserdu (elacestrant)
Lynparza (olaparib) vs Phesgo (pertuzumab, trastuzumab, and hyaluronidase)
Lynparza (olaparib) vs Piqray (alpelisib)
Lynparza (olaparib) vs Talzenna (talazoparib)
Lynparza (olaparib) vs Trodelvy (sacituzumab govitecan-hziy)
Lynparza (olaparib) vs Truqap (capivasertib)
Lynparza (olaparib) vs Tukysa (tucatinib)
Lynparza (olaparib) vs Verzenio/Verzenios (abemaciclib)
Lynparza (olaparib) vs Xeloda ()
Margenza (margetuximab-cmkb) vs Orserdu (elacestrant)
Margenza (margetuximab-cmkb) vs Truqap (capivasertib)
Nerlynx (neratinib) vs Enhertu (fam-trastuzumab deruxtecan-nxki)
Nerlynx (neratinib) vs Kadcyla (trastuzumab emtansine)
Nerlynx (neratinib) vs Margenza (margetuximab-cmkb)
Nerlynx (neratinib) vs Orserdu (elacestrant)
Nerlynx (neratinib) vs Phesgo (pertuzumab, trastuzumab, and hyaluronidase)
Nerlynx (neratinib) vs Piqray (alpelisib)
Nerlynx (neratinib) vs Talzenna (talazoparib)
Nerlynx (neratinib) vs Trodelvy (sacituzumab govitecan-hziy)
Nerlynx (neratinib) vs Truqap (capivasertib)
Nerlynx (neratinib) vs Tukysa (tucatinib)
Orserdu (elacestrant) vs Truqap (capivasertib)
Perjeta (Pertuzumab) vs Afinitor (everolimus)
Perjeta (Pertuzumab) vs Enhertu (fam-trastuzumab deruxtecan-nxki)
Perjeta (Pertuzumab) vs Ibrance (palbociclib)
Perjeta (Pertuzumab) vs Kadcyla (trastuzumab emtansine)
Perjeta (Pertuzumab) vs Keytruda (pembrolizumab)
Perjeta (Pertuzumab) vs Kisqali (ribociclib)
Perjeta (Pertuzumab) vs Lynparza (olaparib)
Perjeta (Pertuzumab) vs Margenza (margetuximab-cmkb)
Perjeta (Pertuzumab) vs Nerlynx (neratinib)
Perjeta (Pertuzumab) vs Orserdu (elacestrant)
Perjeta (Pertuzumab) vs Phesgo (pertuzumab, trastuzumab, and hyaluronidase)
Perjeta (Pertuzumab) vs Piqray (alpelisib)
Perjeta (Pertuzumab) vs Talzenna (talazoparib)
Perjeta (Pertuzumab) vs Trodelvy (sacituzumab govitecan-hziy)
Perjeta (Pertuzumab) vs Truqap (capivasertib)
Perjeta (Pertuzumab) vs Tukysa (tucatinib)
Perjeta (Pertuzumab) vs Verzenio/Verzenios (abemaciclib)
Perjeta (Pertuzumab) vs Xeloda ()
Phesgo (pertuzumab, trastuzumab, and hyaluronidase) vs Margenza (margetuximab-cmkb)
Phesgo (pertuzumab, trastuzumab, and hyaluronidase) vs Orserdu (elacestrant)
Phesgo (pertuzumab, trastuzumab, and hyaluronidase) vs Truqap (capivasertib)
Phesgo (pertuzumab, trastuzumab, and hyaluronidase) vs Tukysa (tucatinib)
Piqray (alpelisib) vs Enhertu (fam-trastuzumab deruxtecan-nxki)
Piqray (alpelisib) vs Kadcyla (trastuzumab emtansine)
Piqray (alpelisib) vs Margenza (margetuximab-cmkb)
Piqray (alpelisib) vs Orserdu (elacestrant)
Piqray (alpelisib) vs Phesgo (pertuzumab, trastuzumab, and hyaluronidase)
Piqray (alpelisib) vs Talzenna (talazoparib)
Piqray (alpelisib) vs Trodelvy (sacituzumab govitecan-hziy)
Piqray (alpelisib) vs Truqap (capivasertib)
Piqray (alpelisib) vs Tukysa (tucatinib)
Talzenna (talazoparib) vs Enhertu (fam-trastuzumab deruxtecan-nxki)
Talzenna (talazoparib) vs Kadcyla (trastuzumab emtansine)
Talzenna (talazoparib) vs Margenza (margetuximab-cmkb)
Talzenna (talazoparib) vs Orserdu (elacestrant)
Talzenna (talazoparib) vs Phesgo (pertuzumab, trastuzumab, and hyaluronidase)
Talzenna (talazoparib) vs Trodelvy (sacituzumab govitecan-hziy)
Talzenna (talazoparib) vs Truqap (capivasertib)
Talzenna (talazoparib) vs Tukysa (tucatinib)
Tecentriq (Atezolizumab) vs Ibrance (palbociclib)
Tecentriq (Atezolizumab) vs Kadcyla (trastuzumab emtansine)
Tecentriq (Atezolizumab) vs Kisqali (ribociclib)
Tecentriq (Atezolizumab) vs Lynparza (olaparib)
Tecentriq (Atezolizumab) vs Margenza (margetuximab-cmkb)
Tecentriq (Atezolizumab) vs Nerlynx (neratinib)
Tecentriq (Atezolizumab) vs Orserdu (elacestrant)
Tecentriq (Atezolizumab) vs Perjeta (Pertuzumab)
Tecentriq (Atezolizumab) vs Phesgo (pertuzumab, trastuzumab, and hyaluronidase)
Tecentriq (Atezolizumab) vs Piqray (alpelisib)
Tecentriq (Atezolizumab) vs Talzenna (talazoparib)
Tecentriq (Atezolizumab) vs Trodelvy (sacituzumab govitecan-hziy)
Tecentriq (Atezolizumab) vs Truqap (capivasertib)
Tecentriq (Atezolizumab) vs Tukysa (tucatinib)
Tecentriq (Atezolizumab) vs Verzenio/Verzenios (abemaciclib)
Tecentriq (Atezolizumab) vs Xeloda ()
Trodelvy (sacituzumab govitecan-hziy) vs Margenza (margetuximab-cmkb)
Trodelvy (sacituzumab govitecan-hziy) vs Orserdu (elacestrant)
Trodelvy (sacituzumab govitecan-hziy) vs Phesgo (pertuzumab, trastuzumab, and hyaluronidase)
Trodelvy (sacituzumab govitecan-hziy) vs Truqap (capivasertib)
Trodelvy (sacituzumab govitecan-hziy) vs Tukysa (tucatinib)
Tukysa (tucatinib) vs Margenza (margetuximab-cmkb)
Tukysa (tucatinib) vs Orserdu (elacestrant)
Tukysa (tucatinib) vs Truqap (capivasertib)
Verzenio/Verzenios (abemaciclib) vs Afinitor (everolimus)
Verzenio/Verzenios (abemaciclib) vs Enhertu (fam-trastuzumab deruxtecan-nxki)
Verzenio/Verzenios (abemaciclib) vs Kadcyla (trastuzumab emtansine)
Verzenio/Verzenios (abemaciclib) vs Margenza (margetuximab-cmkb)
Verzenio/Verzenios (abemaciclib) vs Nerlynx (neratinib)
Verzenio/Verzenios (abemaciclib) vs Orserdu (elacestrant)
Verzenio/Verzenios (abemaciclib) vs Phesgo (pertuzumab, trastuzumab, and hyaluronidase)
Verzenio/Verzenios (abemaciclib) vs Piqray (alpelisib)
Verzenio/Verzenios (abemaciclib) vs Talzenna (talazoparib)
Verzenio/Verzenios (abemaciclib) vs Trodelvy (sacituzumab govitecan-hziy)
Verzenio/Verzenios (abemaciclib) vs Truqap (capivasertib)
Verzenio/Verzenios (abemaciclib) vs Tukysa (tucatinib)
Verzenio/Verzenios (abemaciclib) vs Xeloda ()
Xeloda () vs Enhertu (fam-trastuzumab deruxtecan-nxki)
Xeloda () vs Kadcyla (trastuzumab emtansine)
Xeloda () vs Margenza (margetuximab-cmkb)
Xeloda () vs Nerlynx (neratinib)
Xeloda () vs Orserdu (elacestrant)
Xeloda () vs Phesgo (pertuzumab, trastuzumab, and hyaluronidase)
Xeloda () vs Piqray (alpelisib)
Xeloda () vs Talzenna (talazoparib)
Xeloda () vs Trodelvy (sacituzumab govitecan-hziy)
Xeloda () vs Truqap (capivasertib)
Xeloda () vs Tukysa (tucatinib)
US 0